Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation

Vaccine

Volumn 31, Issue 46, 2013, Pages 5430-5434

  Kotsopoulos, Nikolaos ^a,b   Connolly, Mark P ^a,b   Postma, Maarten J ^a   Hutubessy, Raymond C W ^c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b Global Market Access Solutions (GMAS)   (Switzerland)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Developing countries; Fiscal analysis; Immunisation; Population health; Rotavirus; Vaccines

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; COHORT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EDUCATION; GHANA; GOVERNMENT; HEALTH CARE; HEALTH CARE COST; HUMAN; IMMUNIZATION; INVESTMENT; MORBIDITY; MORTALITY; PRIORITY JOURNAL; TAX; VIET NAM;

DEVELOPING COUNTRIES; FISCAL ANALYSIS; IMMUNISATION; POPULATION HEALTH; ROTAVIRUS; VACCINES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; FEMALE; GHANA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; SURVIVAL ANALYSIS; VIETNAM; YOUNG ADULT;

EID: 84886095347     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.09.002     Document Type: Article

References (31)

1. World Health Organization (WHO) WHO guide to identifying the economic consequences of disease and injury 2009, WHO Press, Geneva, Switzerland.
2. House of Commons International Development Committee Tax in developing countries: increasing resources for development. HC 130 [Incorporating HC 1821, Session 2010-12] Published on 23 August 2012 by authority of the House of Commons, London 2013, http://www.publications.parliament.uk/pa/cm201213/cmselect/cmintdev/130/130.pdf.
3. Deogaonkar R., Hutubessy R., van der Putten I., Evers S., Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health 2012, 12:878.
4. Drummond M.F., O'Brien B., Stoddart G.L., Torrance G.W. Methods for the economic evaluation of health care programmes 1997, Oxford University Press, Oxford.
5. Dame Carol Black's Review of the health of Britain's working age population. Working for a healthier tomorrow 2008, Crown Copyright, London. http://www.dwp.gov.uk/docs/hwwb-working-for-a-healthier-tomorrow.pdf.
6. Sala-i-Martin X., Doppelhofer G., Miller R.I. Determinants of long-term growth: a Bayesian averaging of classical estimates (BACE) approach. Am Econ Rev 2004, 94(4):813-835.
7. van Zon A., Muysken J. Health as a principle determinant of economic growth. Health and economic growth 2005, The MIT Press, Cambridge, MA. G. Lopez-Casasnovas, B. Rivera, L. Currais (Eds.).
8. Sancak C., Velloso R., Jing X. Tax revenue response to the business cycle. International Monetary Fund (IMF) Working Paper No. 10/71 2010, http://211.253.40.86/mille/service/ers/20000/IMG/000000019386/wp1071.pdf.
9. OECD Education at a glance 2011: OECD indicators 2011, OECD Publishing. 10.1787/eag-2011-en.
10. WHO Estimated rotavirus deaths for children under 5 years of age: 2008, 453,000 2008, http://www.who.int/immunization_monitoring/burden/rotavirus_estimates/en/.
11. Atherly D., Dreibelbis R., Parashar U.D., Levin C., Wecker J., Rheingans R.D. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries. J Infect Dis 2009, 2009(Suppl. 1):S28-S38.
12. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis 2003, 9:565-572.
13. Standaert B., Harlin O., Desselberger U. The financial burden of rotavirus disease in four countries of the European Union. Pediatr Infect Dis J 2008, 27:S20-S27.
14. Connolly M.P., Topachevskyi O., Standaert B., Ortega O., Postma M. The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis. PharmacoEconomics 2012, 30:681-695.
15. Auerbach A.J., Kotlikoff L.J., Leibfritz W. Generational accounting around the world 1999, National Bureau of Economic Research University of Chicago Press. http://www.nber.org/books/auer99-1.
16. Abbott C., Tiede B., Armah G., Mahmoud A. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana. Vaccine 2012, 30:2582-2587.
17. Tu H.A., Rozenbaum M.H., Coyte P.C., Li S.C., Woerdenbag H.J., Postma M.J. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries. Vaccine 2012, 30:1521-1528.
18. UNICEF Vaccine price data 2013, http://www.unicef.org/supply/index_57476.html.
19. Bank of Ghana 2013, http://www.bog.gov.gh/index.php/statistics/time-series-data.
20. State Bank of Vietnam 2013, http://www.sbv.gov.vn/wps/portal/vn.
21. Ghana Statistical Service (GSS): Ghana Living Standards Survey Report of the Fifth Round (GLSS 5). Copyright GSS 2008, http://www.statsghana.gov.gh/docfiles/glss5_report.pdf.
22. USAID Educational quality improvement program: meeting EFA. Cost-effectiveness of complementary approaches 2013, http://www.equip123.net/docs/e2-MeetingEFA_WP.pdf.
23. General Statistics Office of Vietnam 2013, http://www.gso.gov.vn/default_en.aspx?tabid=491.
24. Ghana revenue authority: domestic taxes 2012, http://www.gra.gov.gh/index.php?option=com_content&view=article&id=41&Itemid=46.
25. Price Waterhouse Coopers: Vietnam Pocket Tax Book 2012, http://www.pwc.com/en_VN/vn/publications/2012/assets/PwC_Vietnam_Vietnam_Pocket_Tax_Book_2012_English.pdf.
26. Schneider F., Buehn A., Montenegro C.E. New estimates for the shadow economies all over the world. Int Econ J 2010, 24:443-461.
27. WHO Commission on Macroeconomics and Health Working Group 1. Health, economic growth and poverty reduction: the report of Working Group I of the Commission on Macroeconomics and Health 2002, © World Health Organization.
28. Walker D.G., Hutubessy R., Beutels P. WHO Guide for standardisation of economic evaluations of immunization programmes. Vaccine 2010, 11:2356-2359.
29. Garrison L.P., Mansley E.C., Abbott T.A., Breshahan B.W., Hay J.W., Smeeding J. Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force Report-Part II. Value Health 2010, 13:8-13.
30. OECD Taxation, state building and aid. Factsheet, Paris 2009, http://www.oecd.org/development/governanceanddevelopment/46143022.pdf.
31. Prušvic D., Pavlokova K. Generational accounting in European health care systems. Czech J Econ Financ 2010, 60:378-399.